Selected research
Market Structure
Global Pharmacokinetics Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmacokinetics Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pharmacokinetics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmacokinetics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmacokinetics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmacokinetics Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmacokinetics Software include Certara, Simulations Plus, IntiQuan GmbH, Bayer, Genedata AG, Thermo Scientific, SGS, Pharmaron and Pumas-AI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pharmacokinetics Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmacokinetics Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmacokinetics Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacokinetics Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmacokinetics Software Segment by Company
Certara
Simulations Plus
IntiQuan GmbH
Bayer
Genedata AG
Thermo Scientific
SGS
Pharmaron
Pumas-AI
PharmoGo
Chuangteng Technology
Medixi Biomedical
Pharmacokinetics Software Segment by Type
Compartmental Model
Non-Compartmental Models
Pharmacokinetics Software Segment by Application
Experimental Design
Clinical Pharmacokinetics
Other
Pharmacokinetics Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetics Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetics Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetics Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacokinetics Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacokinetics Software industry.
Chapter 3: Detailed analysis of Pharmacokinetics Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacokinetics Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Compartmental Model
- Non-Compartmental Models
Applications
- Experimental Design
- Clinical Pharmacokinetics
- Other
Companies covered
- Certara
- Simulations Plus
- IntiQuan GmbH
- Bayer
- Genedata AG
- Thermo Scientific
- SGS
- Pharmaron
- Pumas-AI
- PharmoGo
- Chuangteng Technology
- Medixi Biomedical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmacokinetics Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Compartmental Model
- 1.2.3 Non-Compartmental Models
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharmacokinetics Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Experimental Design
- 1.3.3 Clinical Pharmacokinetics
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharmacokinetics Software Growth Trends by Region
- 1.5.1 Global Pharmacokinetics Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharmacokinetics Software Market Size by Region (2021-2026)
- 1.5.3 Pharmacokinetics Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharmacokinetics Software Market Dynamics
- 2.1 Pharmacokinetics Software Industry Trends
- 2.2 Pharmacokinetics Software Industry Drivers
- 2.3 Pharmacokinetics Software Industry Opportunities and Challenges
- 2.4 Pharmacokinetics Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharmacokinetics Software Revenue by Company (2021-2026)
- 3.2 Global Pharmacokinetics Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharmacokinetics Software Key Company Head office and Area Served
- 3.4 Global Pharmacokinetics Software Company, Product Type & Application
- 3.5 Global Pharmacokinetics Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharmacokinetics Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharmacokinetics Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharmacokinetics Software Tier 1, Tier 2, and Tier 3
4 Pharmacokinetics Software Market by Type
- 4.1 Global Pharmacokinetics Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharmacokinetics Software Market Size by Type (2021-2032)
- 4.3 Global Pharmacokinetics Software Market Size Share by Type (2021-2032)
5 Pharmacokinetics Software Market by Application
- 5.1 Global Pharmacokinetics Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharmacokinetics Software Market Size by Application (2021-2032)
- 5.3 Global Pharmacokinetics Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Certara
- 6.1.1 Certara Company Information
- 6.1.2 Certara Business Overview
- 6.1.3 Certara Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Certara Pharmacokinetics Software Product Portfolio
- 6.1.5 Certara Recent Developments
- 6.2 Simulations Plus
- 6.2.1 Simulations Plus Company Information
- 6.2.2 Simulations Plus Business Overview
- 6.2.3 Simulations Plus Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Simulations Plus Pharmacokinetics Software Product Portfolio
- 6.2.5 Simulations Plus Recent Developments
- 6.3 IntiQuan GmbH
- 6.3.1 IntiQuan GmbH Company Information
- 6.3.2 IntiQuan GmbH Business Overview
- 6.3.3 IntiQuan GmbH Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 IntiQuan GmbH Pharmacokinetics Software Product Portfolio
- 6.3.5 IntiQuan GmbH Recent Developments
- 6.4 Bayer
- 6.4.1 Bayer Company Information
- 6.4.2 Bayer Business Overview
- 6.4.3 Bayer Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bayer Pharmacokinetics Software Product Portfolio
- 6.4.5 Bayer Recent Developments
- 6.5 Genedata AG
- 6.5.1 Genedata AG Company Information
- 6.5.2 Genedata AG Business Overview
- 6.5.3 Genedata AG Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Genedata AG Pharmacokinetics Software Product Portfolio
- 6.5.5 Genedata AG Recent Developments
- 6.6 Thermo Scientific
- 6.6.1 Thermo Scientific Company Information
- 6.6.2 Thermo Scientific Business Overview
- 6.6.3 Thermo Scientific Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Thermo Scientific Pharmacokinetics Software Product Portfolio
- 6.6.5 Thermo Scientific Recent Developments
- 6.7 SGS
- 6.7.1 SGS Company Information
- 6.7.2 SGS Business Overview
- 6.7.3 SGS Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 SGS Pharmacokinetics Software Product Portfolio
- 6.7.5 SGS Recent Developments
- 6.8 Pharmaron
- 6.8.1 Pharmaron Company Information
- 6.8.2 Pharmaron Business Overview
- 6.8.3 Pharmaron Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Pharmaron Pharmacokinetics Software Product Portfolio
- 6.8.5 Pharmaron Recent Developments
- 6.9 Pumas-AI
- 6.9.1 Pumas-AI Company Information
- 6.9.2 Pumas-AI Business Overview
- 6.9.3 Pumas-AI Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Pumas-AI Pharmacokinetics Software Product Portfolio
- 6.9.5 Pumas-AI Recent Developments
- 6.10 PharmoGo
- 6.10.1 PharmoGo Company Information
- 6.10.2 PharmoGo Business Overview
- 6.10.3 PharmoGo Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 PharmoGo Pharmacokinetics Software Product Portfolio
- 6.10.5 PharmoGo Recent Developments
- 6.11 Chuangteng Technology
- 6.11.1 Chuangteng Technology Company Information
- 6.11.2 Chuangteng Technology Business Overview
- 6.11.3 Chuangteng Technology Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Chuangteng Technology Pharmacokinetics Software Product Portfolio
- 6.11.5 Chuangteng Technology Recent Developments
- 6.12 Medixi Biomedical
- 6.12.1 Medixi Biomedical Company Information
- 6.12.2 Medixi Biomedical Business Overview
- 6.12.3 Medixi Biomedical Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Medixi Biomedical Pharmacokinetics Software Product Portfolio
- 6.12.5 Medixi Biomedical Recent Developments
7 North America
- 7.1 North America Pharmacokinetics Software Market Size (2021-2032)
- 7.2 North America Pharmacokinetics Software Market Size by Type
- 7.2.1 North America Pharmacokinetics Software Market Size by Type (2021-2026)
- 7.2.2 North America Pharmacokinetics Software Market Size by Type (2027-2032)
- 7.2.3 North America Pharmacokinetics Software Market Share by Type (2021-2032)
- 7.3 North America Pharmacokinetics Software Market Size by Application
- 7.3.1 North America Pharmacokinetics Software Market Size by Application (2021-2026)
- 7.3.2 North America Pharmacokinetics Software Market Size by Application (2027-2032)
- 7.3.3 North America Pharmacokinetics Software Market Share by Application (2021-2032)
- 7.4 North America Pharmacokinetics Software Market Size by Country
- 7.4.1 North America Pharmacokinetics Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharmacokinetics Software Market Size by Country (2021-2026)
- 7.4.3 North America Pharmacokinetics Software Market Size by Country (2027-2032)
- 7.4.4 North America Pharmacokinetics Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharmacokinetics Software Market Size (2021-2032)
- 8.2 Europe Pharmacokinetics Software Market Size by Type
- 8.2.1 Europe Pharmacokinetics Software Market Size by Type (2021-2026)
- 8.2.2 Europe Pharmacokinetics Software Market Size by Type (2027-2032)
- 8.2.3 Europe Pharmacokinetics Software Market Share by Type (2021-2032)
- 8.3 Europe Pharmacokinetics Software Market Size by Application
- 8.3.1 Europe Pharmacokinetics Software Market Size by Application (2021-2026)
- 8.3.2 Europe Pharmacokinetics Software Market Size by Application (2027-2032)
- 8.3.3 Europe Pharmacokinetics Software Market Share by Application (2021-2032)
- 8.4 Europe Pharmacokinetics Software Market Size by Country
- 8.4.1 Europe Pharmacokinetics Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharmacokinetics Software Market Size by Country (2021-2026)
- 8.4.3 Europe Pharmacokinetics Software Market Size by Country (2027-2032)
- 8.4.4 Europe Pharmacokinetics Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharmacokinetics Software Market Size (2021-2032)
- 9.2 China Pharmacokinetics Software Market Size by Type
- 9.2.1 China Pharmacokinetics Software Market Size by Type (2021-2026)
- 9.2.2 China Pharmacokinetics Software Market Size by Type (2027-2032)
- 9.2.3 China Pharmacokinetics Software Market Share by Type (2021-2032)
- 9.3 China Pharmacokinetics Software Market Size by Application
- 9.3.1 China Pharmacokinetics Software Market Size by Application (2021-2026)
- 9.3.2 China Pharmacokinetics Software Market Size by Application (2027-2032)
- 9.3.3 China Pharmacokinetics Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharmacokinetics Software Market Size (2021-2032)
- 10.2 Asia Pharmacokinetics Software Market Size by Type
- 10.2.1 Asia Pharmacokinetics Software Market Size by Type (2021-2026)
- 10.2.2 Asia Pharmacokinetics Software Market Size by Type (2027-2032)
- 10.2.3 Asia Pharmacokinetics Software Market Share by Type (2021-2032)
- 10.3 Asia Pharmacokinetics Software Market Size by Application
- 10.3.1 Asia Pharmacokinetics Software Market Size by Application (2021-2026)
- 10.3.2 Asia Pharmacokinetics Software Market Size by Application (2027-2032)
- 10.3.3 Asia Pharmacokinetics Software Market Share by Application (2021-2032)
- 10.4 Asia Pharmacokinetics Software Market Size by Country
- 10.4.1 Asia Pharmacokinetics Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharmacokinetics Software Market Size by Country (2021-2026)
- 10.4.3 Asia Pharmacokinetics Software Market Size by Country (2027-2032)
- 10.4.4 Asia Pharmacokinetics Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharmacokinetics Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharmacokinetics Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharmacokinetics Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharmacokinetics Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharmacokinetics Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharmacokinetics Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharmacokinetics Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharmacokinetics Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharmacokinetics Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharmacokinetics Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharmacokinetics Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharmacokinetics Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharmacokinetics Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharmacokinetics Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst